Chemoprevention of prostate cancer via estrogen receptor beta agonists

Ended Awarded Sep 18, 2013 Last action Feb 15, 2018

Master IDIQ Preclinical Efficacy and Intermediate Endpoint Biomarkers
Indefinite Delivery Contract HHSN261201200016I
Delivery Order This award

Contract number: HHSN26100003
Awardee: IIT Research Institute UEI DGBUFQYMKWB5
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $685,413

Award facts

Opportunity: N01CN2500278 Solicitation number

Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Feb 27, 2012

Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Dec 15, 2011
Contract value 100% obligated: $685,413.18 Current and potential, with all options
Completion date 100% complete: Oct 17, 2016 Current and potential, with all options
NAICS code: 541711 Research and Development in Biotechnology
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing: Firm Fixed Price
Place of performance: Chicago, IL 60616, USA

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Close Out 5 · Chemoprevention of prostate cancer via estrogen RECEPTOR61538; beta agoniststhe purpose of this modification is to update the period of performance. The…	-$846	Feb 15, 2018
Other Administrative Action 4	$0	Sep 14, 2016
Other Administrative Action 3	$0	May 26, 2016
Other Administrative Action 2	$0	Sep 17, 2015
Other Administrative Action 1 · Preclinical efficacy and intermediate endpoint biomarkers: chemoprevention of prostate cancer via estrogen receptor beta agonists	$0	Mar 23, 2015
Original award	$686,259	Sep 16, 2013

Quick answers

Who was awarded contract HHSN26100003?

HHSN26100003 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 18, 2013.

How much is contract HHSN26100003 worth?

The government has obligated $685,413 on HHSN26100003.

Is contract HHSN26100003 an order under another contract?

Yes. HHSN26100003 is a delivery order under HHSN261201200016I, an indefinite delivery contract, on Preclinical Efficacy and Intermediate Endpoint Biomarkers.

Was contract HHSN26100003 competed?

The extent of competition for HHSN26100003 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login